Intrac, Inc. (OTCBB:ITRD) (“Intrac” or the “Company”) and certain of its security holders have executed a non-binding Term Sheet with Innovative Drug Delivery Systems, Inc. (“IDDS”), a privately-held company which is a development stage specialty pharmaceutical company that applies proprietary technologies to develop new drugs and improved formulations of existing drugs for the prescription pain management market.
